-
Mashup Score: 1The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study - PubMed - 2 year(s) ago
Older, multimorbid patients may derive QALY gains from adjuvant chemotherapy after NSCLC surgery. These results help extend existing clinical trial data to specific unstudied, high-risk populations and may reduce the uncertainty regarding adjuvant chemotherapy use in these patients.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations - PubMed - 2 year(s) ago
Researchers have made crucial advances in understanding the pathogenesis and therapeutics of non-small cell lung cancer (NSCLC), improving our understanding of lung tumor biology and progression. Although the survival of NSCLC patients has improved due to chemoradiotherapy, targeted therapy, and imm …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2Significance and potential role of eosinophils in non-cystic fibrosis bronchiectasis - 2 year(s) ago
Bronchiectasis is a complex and heterogeneous disease caused by a myriad of pulmonary and extrapulmonary aetiologies. Bronchiectasis has a predominantly neutrophilic inflammatory profile, however, eosinophilic inflammation has also been documented in both the airways and systemic circulation. Various diseases (e.g. asthma, allergic bronchopulmonary aspergillosis, chronic rhinosinusitis with nasal…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
NCT03223805.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study - PubMed - 2 year(s) ago
The Netherlands Trial Register, NL7025.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2
Among patients with suspected early-stage non-small cell lung cancer (NSCLC), we sought to evaluate the association of patient-clinician communication (PCC) with patient-centered outcomes (PCOs). We conducted a multicenter, prospective cohort study examining PCOs at five time points, up to 12-months …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1Focus on long non-coding RNA MALAT1: Insights into acute and chronic lung diseases - PubMed - 2 year(s) ago
Acute lung injury (ALI) is a pulmonary illness with a high burden of morbidity and mortality around the world. Chronic lung diseases also represent life-threatening situations. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a type of long non-coding RNA (lncRNA) and is highly abu …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Chemotherapy is the first choice for the treatment of cancer but it is still limited by insufficient kill efficiency and drug resistance. These problems urgently need to be overcome in a way that minimizes damage to the body. In this study, we designed the nanocomposite microparticles (NMPs) modifie …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor - PubMed - 2 year(s) ago
Elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) was shown to be safe and efficacious in people with cystic fibrosis (CF) heterozygous for F508del and a minimal function mutation (F/MF) or homozygous for F508del (F/F) in two pivotal Phase 3 trials, significantly improving percentage predicted forced e …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
The benefits and harms of #adjuvant #chemotherapy for #non- #small #cell #lung #cancer in patients with #major #comorbidities: A simulation study #NSCLC #LungCancer https://t.co/noglJSJmk7 https://t.co/igsO9gwSny